69 related articles for article (PubMed ID: 10553066)
21. Supraphysiological Levels of IL-2 in Jak3-Deficient Mice Promote Strong Proliferative Responses of Adoptively Transferred Naive CD8
Lee GW; Lee SW; Kim J; Ju YJ; Kim HO; Yun CH; Cho JH
Front Immunol; 2020; 11():616898. PubMed ID: 33584707
[TBL] [Abstract][Full Text] [Related]
22. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells.
Kirken RA; Erwin RA; Taub D; Murphy WJ; Behbod F; Wang L; Pericle F; Farrar WL
J Leukoc Biol; 1999 Jun; 65(6):891-9. PubMed ID: 10380915
[TBL] [Abstract][Full Text] [Related]
23. Defective signaling in a subpopulation of CD4(+) T cells in the absence of Ca(2+)/calmodulin-dependent protein kinase IV.
Anderson KA; Means AR
Mol Cell Biol; 2002 Jan; 22(1):23-9. PubMed ID: 11739719
[TBL] [Abstract][Full Text] [Related]
24. Defective Fas ligand expression and activation-induced cell death in the absence of IL-2-inducible T cell kinase.
Miller AT; Berg LJ
J Immunol; 2002 Mar; 168(5):2163-72. PubMed ID: 11859102
[TBL] [Abstract][Full Text] [Related]
25. Unexpected and variable phenotypes in a family with JAK3 deficiency.
Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
[TBL] [Abstract][Full Text] [Related]
26. Crucial role of Jak3 in negative selection of self-reactive T cells.
Saijo K; Park SY; Ishida Y; Arase H; Saito T
J Exp Med; 1997 Jan; 185(2):351-6. PubMed ID: 9016883
[TBL] [Abstract][Full Text] [Related]
27. Defective lymphoid development in mice lacking Jak3.
Nosaka T; van Deursen JM; Tripp RA; Thierfelder WE; Witthuhn BA; McMickle AP; Doherty PC; Grosveld GC; Ihle JN
Science; 1995 Nov; 270(5237):800-2. PubMed ID: 7481769
[TBL] [Abstract][Full Text] [Related]
28. Jak3-regulated genes: DNA array analysis of concanavalin a-interleukin-2-activated chicken T cells treated with a specific jak3 inhibitor.
Kampa D; Burnside J
J Interferon Cytokine Res; 2002 Sep; 22(9):975-80. PubMed ID: 12396719
[TBL] [Abstract][Full Text] [Related]
29. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
Brugnoni D; Notarangelo LD; Sottini A; Airò P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
[TBL] [Abstract][Full Text] [Related]
30. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
Bunting KD; Lu T; Kelly PF; Sorrentino BP
Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440
[TBL] [Abstract][Full Text] [Related]
31. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
[TBL] [Abstract][Full Text] [Related]
32. Single-cell analyses reveal two defects in peptide-specific activation of naive T cells from aged mice.
Garcia GG; Miller RA
J Immunol; 2001 Mar; 166(5):3151-7. PubMed ID: 11207267
[TBL] [Abstract][Full Text] [Related]
33. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice.
Park SY; Saijo K; Takahashi T; Osawa M; Arase H; Hirayama N; Miyake K; Nakauchi H; Shirasawa T; Saito T
Immunity; 1995 Dec; 3(6):771-82. PubMed ID: 8777722
[TBL] [Abstract][Full Text] [Related]
34. The role of Jak3 in lymphoid development, activation, and signaling.
Thomis DC; Berg LJ
Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175
[TBL] [Abstract][Full Text] [Related]
35. Accumulation of NFAT mediates IL-2 expression in memory, but not naïve, CD4+ T cells.
Dienz O; Eaton SM; Krahl TJ; Diehl S; Charland C; Dodge J; Swain SL; Budd RC; Haynes L; Rincon M
Proc Natl Acad Sci U S A; 2007 Apr; 104(17):7175-80. PubMed ID: 17438271
[TBL] [Abstract][Full Text] [Related]
36. A profound deficiency in thymic progenitor cells in mice lacking Jak3.
Baird AM; Lucas JA; Berg LJ
J Immunol; 2000 Oct; 165(7):3680-8. PubMed ID: 11034372
[TBL] [Abstract][Full Text] [Related]
37. Essential biphasic role for JAK3 catalytic activity in IL-2 receptor signaling.
Smith GA; Uchida K; Weiss A; Taunton J
Nat Chem Biol; 2016 May; 12(5):373-9. PubMed ID: 27018889
[TBL] [Abstract][Full Text] [Related]
38. Revised exon-intron structure of human JAK3 locus.
Brooimans RA; van der Slot AJ; van den Berg AJ; Zegers BJ
Eur J Hum Genet; 1999; 7(7):837-40. PubMed ID: 10573019
[TBL] [Abstract][Full Text] [Related]
39. A kinase-deficient splice variant of the human JAK3 is expressed in hematopoietic and epithelial cancer cells.
Lai KS; Jin Y; Graham DK; Witthuhn BA; Ihle JN; Liu ET
J Biol Chem; 1995 Oct; 270(42):25028-36. PubMed ID: 7559633
[TBL] [Abstract][Full Text] [Related]
40. Dysregulated myelopoiesis in mice lacking Jak3.
Grossman WJ; Verbsky JW; Yang L; Berg LJ; Fields LE; Chaplin DD; Ratner L
Blood; 1999 Aug; 94(3):932-9. PubMed ID: 10419884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
